PT Multi Medika Internasional Tbk (IDX:MMIX)
302.00
+2.00 (0.67%)
At close: Apr 28, 2026
IDX:MMIX Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 201,472 | 191,991 | 175,134 | 175,094 | 181,842 | Upgrade
|
| Revenue Growth (YoY) | 4.94% | 9.63% | 0.02% | -3.71% | 2965.83% | Upgrade
|
| Cost of Revenue | 79,782 | 81,686 | 71,832 | 84,014 | 114,249 | Upgrade
|
| Gross Profit | 121,690 | 110,305 | 103,302 | 91,080 | 67,593 | Upgrade
|
| Selling, General & Admin | 82,679 | 90,276 | 75,182 | 58,832 | 31,226 | Upgrade
|
| Other Operating Expenses | 7,622 | 651.48 | 2,642 | 948.51 | 2,934 | Upgrade
|
| Operating Expenses | 90,301 | 90,928 | 77,824 | 59,780 | 34,160 | Upgrade
|
| Operating Income | 31,390 | 19,377 | 25,479 | 31,300 | 33,433 | Upgrade
|
| Interest Expense | -1,138 | -2,864 | -1,293 | -678.56 | -883.14 | Upgrade
|
| Interest & Investment Income | 108.83 | 740.76 | 130.79 | 84.68 | 18.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 122.64 | 50 | 37.74 | - | 4.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -22,671 | -15,524 | -2,826 | -200.11 | -360 | Upgrade
|
| Pretax Income | 7,813 | 1,779 | 21,528 | 30,506 | 32,213 | Upgrade
|
| Income Tax Expense | 2,574 | 572.53 | 5,015 | 6,838 | 7,168 | Upgrade
|
| Net Income | 5,239 | 1,207 | 16,513 | 23,668 | 25,045 | Upgrade
|
| Net Income to Common | 5,239 | 1,207 | 16,513 | 23,668 | 25,045 | Upgrade
|
| Net Income Growth | 334.02% | -92.69% | -30.23% | -5.50% | 1674.33% | Upgrade
|
| Shares Outstanding (Basic) | 2,801 | 4,800 | 3,456 | 4,001 | 3,280 | Upgrade
|
| Shares Outstanding (Diluted) | 2,801 | 4,800 | 3,456 | 4,001 | 3,280 | Upgrade
|
| Shares Change (YoY) | -41.64% | 38.90% | -13.62% | 21.98% | - | Upgrade
|
| EPS (Basic) | 1.87 | 0.25 | 4.78 | 5.92 | 7.64 | Upgrade
|
| EPS (Diluted) | 1.87 | 0.25 | 4.78 | 5.92 | 7.64 | Upgrade
|
| EPS Growth | 643.73% | -94.74% | -19.23% | -22.53% | - | Upgrade
|
| Free Cash Flow | 45,842 | -124,593 | -110,023 | -41,549 | 4,708 | Upgrade
|
| Free Cash Flow Per Share | 16.36 | -25.95 | -31.84 | -10.38 | 1.44 | Upgrade
|
| Gross Margin | 60.40% | 57.45% | 58.98% | 52.02% | 37.17% | Upgrade
|
| Operating Margin | 15.58% | 10.09% | 14.55% | 17.88% | 18.39% | Upgrade
|
| Profit Margin | 2.60% | 0.63% | 9.43% | 13.52% | 13.77% | Upgrade
|
| Free Cash Flow Margin | 22.75% | -64.89% | -62.82% | -23.73% | 2.59% | Upgrade
|
| EBITDA | 113,501 | 26,516 | 29,320 | 32,081 | 33,571 | Upgrade
|
| EBITDA Margin | 56.34% | 13.81% | 16.74% | 18.32% | 18.46% | Upgrade
|
| D&A For EBITDA | 82,111 | 7,139 | 3,841 | 780.69 | 138.03 | Upgrade
|
| EBIT | 31,390 | 19,377 | 25,479 | 31,300 | 33,433 | Upgrade
|
| EBIT Margin | 15.58% | 10.09% | 14.55% | 17.88% | 18.39% | Upgrade
|
| Effective Tax Rate | 32.95% | 32.17% | 23.30% | 22.41% | 22.25% | Upgrade
|
| Advertising Expenses | 12,853 | 22,246 | 25,601 | 28,176 | 8,517 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.